{
    "nct_id": "NCT06205836",
    "official_title": "Evaluating a Surgical-Sparing Approach Using Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer",
    "inclusion_criteria": "* Age â‰¥70 years.\n* Eastern Cooperative Oncology Group (ECOG) performance status 0 -2\n* Have histologically proven localized or locally advanced mismatch repair deficient (dMMR) or microsatellite unstable (MSI-H) colorectal cancer.\n* Must not have received any prior systemic treatment or radiation.\n* Must be agreeable to endoscopic, and CT surveillance for a total of 24 months.\n* Patient's acceptance to have a tumor biopsy.\n* Patients must have adequate organ and marrow function defined by study-specified laboratory tests and procedures.\n* For both Women and Men, must use acceptable form of birth control while on study.\n* Ability to understand and willingness to sign a written informed consent document.\nHealthy volunteers allowed\nMust have minimum age of 70 Years",
    "exclusion_criteria": "* Have received an investigational agent or used an investigational device within 28 days of the first dose of study drug.\n* Have expected to require any other form of systemic or localized antineoplastic therapy while on study.\n* Have had surgery within 28 days of dosing of investigational agent, excluding minor procedures (dental work, skin biopsy, etc.).\n* History of prior treatment with an anti-PD-1, anti-PD-L1, anti-PD-L2, anti-CTLA4, or anti-Lag-3 antibodies for any reason in the 5 years proceeding their colorectal cancer diagnosis.\n* Currently using any chronic systemic steroids.\n* History of severe hypersensitivity reaction to any monoclonal antibody.\n* Uncontrolled intercurrent illness including, but not limited to, uncontrolled infection, symptomatic congestive heart failure, unstable angina, cardiac arrhythmia, metastatic cancer, or psychiatric illness/social situations that would limit compliance with study requirements.\n* Active autoimmune disease.\n* Any tissue or organ allograft, regardless of need for immunosuppression, including corneal allograft.\n* Patient is on supplemental home oxygen.\n* Has clinically significant heart disease.\n* Conditions, including alcohol or drug dependence, intercurrent illness, or lack of sufficient peripheral venous access, that would affect the patient's ability to comply with study visits and procedures\n* Unwilling or unable to follow the study schedule for any reason",
    "miscellaneous_criteria": ""
}